Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate / / statement of Mary Denigan-Macauley

• Pubblicazione: [Washington, D.C.] : , : United States Government Accountability Office, , 2020
• Descrizione fisica: 1 online resource (26 pages) : color illustrations, color maps
• Soggetto topico: COVID-19 (Disease) - Treatment - United States; Drugs - Inspection - United States; Drugs - United States - Safety measures - Evaluation; Pharmaceutical industry - Quality control - Evaluation; Drugs - Safety regulations - United States - Evaluation; Drug reimportation - United States - Evaluation; Imports - United States - Safety measures - Evaluation
• Persona (resp. second.): Denigan-MacauleyMary
• Note generali: "For release on delivery, expected at 2:30 p.m. ET, Tuesday, June 2, 2020."
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Drug safety
• Titolo autorizzato: Drug safety: COVID-19 complicates already challenged FDA foreign inspection program
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910713508703321
• Lo trovi qui: Univ. Federico II